- Entecavir
drugbox
IUPAC_name = 2-amino-9-[ 4-hydroxy-3-(hydroxymethyl)-
2-methylidene-cyclopentyl] -3"H"-purin-6-one
CAS_number = 142217-69-4
ATC_prefix = J05
ATC_suffix = AF10
ATC_supplemental =
PubChem = 153941
DrugBank = APRD00948
C=12 | H=15 | N=5 | O=3
molecular_weight = 277.279 g/mol
bioavailability =
protein_bound = 13%
metabolism =
elimination_half-life = 128–149 hours
excretion = Renal 62–73%
pregnancy_US = C
legal_US = Rx-only
routes_of_administration = Oral
licence_EU =Baraclude
licence_US =EntecavirEntecavir (INN) (pronEng|ɛnˈtɛkəvɪr) is an oral
antiviral drug used in the treatment ofhepatitis B infection. It is marketed under the trade name Baraclude (BMS).Entecavir is a guanine analogue that inhibits reverse transcription, DNA replication and transcription in the viral replication process, and the manufacturer claims that it is more efficacious than previous agents used to treat hepatitis B (
lamivudine andadefovir ). It was approved by the U.S.Food and Drug Administration (FDA) in March 2005.External links
* [http://www.baraclude.com/ Baraclude U.S. website]
Wikimedia Foundation. 2010.